APR 25, 2019

Infectious Disease 2019





 

Our Inaugural Infectious Disease Virtual Event is now available On-Demand! The event will remain open 6 months from the date of the live event.  The webinars will be available for unlimited on-demand viewing.


Topic's for this years event included: 

  • Stories and Lessons of the Past
  • Current Challenges and Controversies
  • Emerging Tools and Methods


Continuing Education
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 14 credits.

Use #LRinfectious to follow the conversation!


Speakers
  • Associate Professor, Pathology & Laboratory Medicine, Emory University School of Medicine
  • Professor of Epidemiology, Director, Infectious Disease Epidemiology Certificate, Columbia University, Mailman School of Public Health
  • Global Marketing Director, Chembio Diagnostic Systems
  • Director, Market Strategy for Microbial and Cancer Genomics, Pacific Biosciences
  • Senior Associate Scientist, Behavioral Pharmacology and Surgery, Biogen
  • Vice President, Research & Development, Chembio Diagnostic Systems
  • Associate Professor of Medicine and Epidemiology, Division of Infectious Diseases, University of Alabama at Birmingham
  • Director & Professor, Biomedical Informatics Research Center, Laboratory for Pathogenesis of Clinical Drug Resistance and Persistence, San Diego State University
  • Assistant Professor, Department of Biochemistry and Molecular Genetics, University of Louisville School of Medicine

Show Resources
Agenda
  • APR 25, 2019 06:00 AM PDT
    Speaker: Christina Muzny, MD, MSPH, FACP
  • APR 25, 2019 06:00 AM PDT
    Speaker: Meredith Ashby, PhD
    Sponsored By: PacBio
  • APR 25, 2019 07:30 AM PDT
    Speaker: Colleen Kraft, MD, MSc
  • APR 25, 2019 09:00 AM PDT
    Speaker: Stephen Morse, PhD, FAAM, F.A.C.E.
  • APR 25, 2019 10:30 AM PDT
    Sponsored By: Chembio
    Krishnan Allampallam, PhD
    Global Marketing Director, Chembio Diagnostic Systems
    Paul Lambotte, PhD
    Vice President, Research & Development, Chembio Diagnos...
  • APR 25, 2019 10:30 AM PDT
    Speaker: Corey Watson, PhD
  • APR 25, 2019 12:00 PM PDT
    Speaker: Faramarz Valafar, PhD
  • APR 25, 2019 01:30 PM PDT
    Speaker: Matthew Flegal, BS, SRS
  • Current Challenges and Controversies
  • APR 25, 2019 06:00 AM PDT
    Speaker: Christina Muzny, MD, MSPH, FACP
  • APR 25, 2019 09:00 AM PDT
    Speaker: Stephen Morse, PhD, FAAM, F.A.C.E.
  • APR 25, 2019 10:30 AM PDT
    Speaker: Corey Watson, PhD
  • APR 25, 2019 12:00 PM PDT
    Speaker: Faramarz Valafar, PhD
  • Emerging Tools and Methods
  • APR 25, 2019 06:00 AM PDT
    Speaker: Meredith Ashby, PhD
    Sponsored By: PacBio
  • APR 25, 2019 10:30 AM PDT
    Sponsored By: Chembio
    Krishnan Allampallam, PhD
    Global Marketing Director, Chembio Diagnostic Systems
    Paul Lambotte, PhD
    Vice President, Research & Development, Chembio Diagnos...
  • Stories and Lessons of the Past
  • APR 25, 2019 07:30 AM PDT
    Speaker: Colleen Kraft, MD, MSc
  • APR 25, 2019 01:30 PM PDT
    Speaker: Matthew Flegal, BS, SRS
Posters

POSTER SUBMISSION GUIDELINES

Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer-reviewed. Submission is free.


SUBMIT YOUR ABSTRACT

Enter the following information to this Submission Form:

Poster Title

Your Name

Your Institution

Your Email

Abstract describing the poster


All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

Questions? Email Posters@LabRoots.com

LabRoots Policy

Speakers

  • Colleen Kraft, MD, MSc
    Associate Professor, Pathology & Laboratory Medicine, Emory University School of Medicine
    Biography
      Dr. Colleen Kraft is an infectious diseases-trained physician and a clinical microbiologist. She is a member of the leadership group for the Serious Communicable Diseases Unit at Emory University Hospital in Atlanta, GA. She was one of the physicians in the care of patients with Ebola virus disease and Lassa Fever at Emory University Hospital from 2014-2016. Dr. Kraft is a co-PI for the National Ebola Training and Education Center, a federally funded collaborative between Emory, Nebraska Medicine, and New York Health and Hospital-Bellevue. She is also the PI on the NIOSH PPTL contract to evaluate elastomeric respirators in the healthcare center. Her vision for the Serious Communicable Diseases Unit is to use the subject matter expertise that was gained from the care of these patients with special pathogens and bring those lessons into everyday healthcare.
    • Stephen Morse, PhD, FAAM, F.A.C.E.
      Professor of Epidemiology, Director, Infectious Disease Epidemiology Certificate, Columbia University, Mailman School of Public Health
      Biography
        Stephen S. Morse, Ph.D., is Professor of Epidemiology at the Columbia University Mailman School of Public Health, where he also serves as Director of the Infectious Disease Epidemiology certificate and as chair of the Columbia University Institutional Biosafety Committee (IBC). He was founding Director of the CDC-funded "Center for Public Health Preparedness" (2000-2005). Before coming to Columbia, Dr. Morse was Assistant Professor (virology) in The Rockefeller University (1985-1995), and Program Manager for Biodefense at DARPA (the Defense Advanced Research Projects Agency) from 1995 to 2000. He was appointed in 2014 to the U.S. government's National Science Advisory Board for Biosecurity (NSABB). His research interests focus on infectious disease surveillance, and the epidemiology and assessment of emerging infectious diseases, including influenza. He was Chair of the NIH "Conference on Emerging Viruses" (1989), for which he originated the concept of emerging viruses/infections, was founding chair of ProMED (the Program to Monitor Emerging Diseases, best known for originating outbreak reporting on the Internet in 1994); and served on the Institute of Medicine (now National Academy of Medicine) Committee on Emerging Microbial Threats to Health (1990-1992), and chaired its Virology Task Force. His book Emerging Viruses (Oxford University Press, 1993) was selected by American Scientist as one of "The Top 100 Science Books of the [20th] Century". He was a founding member of the National Academies' "Forum on Emerging Infections" (later renamed the "Forum on Microbial Threats"), a founding section editor of the CDC journal Emerging Infectious Diseases, former Editor-in-Chief of the Pasteur Institute's virology journal, and global co-Director of PREDICT (a USAID project to strengthen global capacity for surveillance and detection of new infectious disease threats) from 2009 to 2014. He is currently an Associate Editor of Disaster Medicine & Public Health Preparedness, and serves on the Editorial Board of several journals, including Health Security and Viral Immunology. He also serves on committees at the National Academies of Sciences and the World Health Organization (WHO), including the WHO Expert Group on Pandemic Influenza Preparedness Planning in the Eastern Mediterranean Region. He is a Fellow of the American Association for the Advancement of Science (AAAS), the American Academy of Microbiology, the American College of Epidemiology, the New York Academy of Medicine, the New York Academy of Sciences (and was Chair of its Microbiology Section), and other professional societies, and is a Life Member of the Council on Foreign Relations. He received his Ph.D. (in microbiology) from the University of Wisconsin-Madison.
      • Krishnan Allampallam, PhD
        Global Marketing Director, Chembio Diagnostic Systems
        Biography
          Krishnan Allampallam joined Chembio Diagnostic Systems, Inc about two years and serves as Global Director of Marketing. Krishnan has spent over 15+ years in the biotechnology industry. Before beginning his career in biotech, Krishnan focused his research in the field of oncology and has authored and co-authored multiple publications, abstracts and book chapters in peer reviewed journals. He received his Ph.D. from University of Toledo Medical Center in 1996 and did post-doctoral research at The Cleveland Clinic and Rush University Medical Center. Currently Krishnan is the Global Director of Marketing at Chembio Diagnostics, a New York Based public company focused on point of care rapid diagnostics. Prior to Chembio, Krishnan held various leadership positions in marketing and global product management.
        • Meredith Ashby, PhD
          Director, Market Strategy for Microbial and Cancer Genomics, Pacific Biosciences
          Biography
            Meredith Ashby is the Director of Market Strategy for Cancer and Microbial Genomics at Pacific Biosciences. She completed her Ph.D. at Caltech mapping the gene regulatory networks that direct sea urchin development just as the sea urchin genome was being sequenced. Inspired by the impact of genome sequencing on her research, she joined PacBio after a brief postdoc at UCSF. She has been with the company since 2009, and has worked in R&D on both sequencing optimization and bioinformatics application development. She is now focused on exploring and facilitating the use of PacBio long read sequencing to solve the unmet needs of scientists studying how the wide range of human genetic variation impacts health and disease.
          • Matthew Flegal, BS, SRS
            Senior Associate Scientist, Behavioral Pharmacology and Surgery, Biogen
            Biography
              Matt entered the research field over 24 years ago as a lab animal technician at the TSI/Mason contract research facility. Since then, he has worked at contract facilities such as TSI and OREAD Biosafety as well as in industry at Pharmacia, Pfizer, Sanofi-Aventis, and Biogen. During that period he has performed a variety of surgical procedures including device implantation, transplants, orthopedic defect, ocular and vascular implants, cardiac surgery, and brain and spinal procedures. His experience ranges from mice and rats to non-human primates and livestock. In addition, he holds four patents for novel surgical devices and implants and has been training technicians, scientists, veterinarians, and physicians in surgical techniques and procedures for over 18 years. Outside of the surgical realm, he has been a study director, sonographer, Safety Pharmacology scientist, and manager. Currently Matt supervises a team of associates at Biogen who conduct surgical and non-surgical studies. Matt was also on the board of directors for the Academy of Surgical Research for over ten years, serving as their program chair for three of them as well as educational chair for two. Currently he is the program chairman for the New England branch of AALAS.
            • Paul Lambotte, PhD
              Vice President, Research & Development, Chembio Diagnostic Systems
              Biography
                Paul Lambotte joined Chembio Diagnostic Systems, Inc. in December 2014, and serves as Vice President of Product Development. Prior to joining the company, Mr. Lambotte was President of PLC Inc., a POC product development consulting company. He previously served as Chief Science Officer at Axxin Pty Ltd, held positions of VP of R&D and Business Development at Quidel Corporation, and held a number of positions at Beckman Coulter and Hybritech Inc. Mr. Lambotte is the inventor of several patents in the field of rapid, point-of-care diagnostic products. He received a Master in Biochemistry and a PhD in Protein Biochemistry from the University of Mons, Belgium, and did post-doctoral work at the Ludwig Institute for Cancer research in Brussels, Belgium.
              • Christina Muzny, MD, MSPH, FACP
                Associate Professor of Medicine and Epidemiology, Division of Infectious Diseases, University of Alabama at Birmingham
                Biography
                  Dr. Christina Muzny obtained her medical degree at the Texas A&M University Health Sciences Center College of Medicine. She subsequently completed an internal medicine residency and an infectious diseases fellowship at the University of Mississippi Medical Center prior to joining the infectious diseases faculty at the University of Alabama at Birmingham (UAB) in 2010. Her clinical and research interests focus on HIV and sexually transmitted diseases (specifically vaginal infections) among sexual minority women of color and women with increased numbers of recent sexual partners. Dr. Muzny currently has a K23 career development award from the National Institute of Allergy and Infectious Diseases to study the pathogenesis of bacterial vaginosis among African American women who have sex with women. She is currently an Associate Professor in the Division of Infectious Diseases at UAB, a teaching faculty for the Alabama-North Carolina STD/HIV Prevention Training Center, and an Associate Scientist for the UAB Center for AIDS Research.
                • Faramarz Valafar, PhD
                  Director & Professor, Biomedical Informatics Research Center, Laboratory for Pathogenesis of Clinical Drug Resistance and Persistence, San Diego State University
                  Biography
                    My work, has been focused on genetic and epigenetic basis for emergence of new phenotypes in Mycobacterium tuberculosis (M. tuberculosis). Within this realm, we have used a wide variety of approaches including long-read Whole Genome Sequencing (WGS), comparative genomics for genome-wide causal variant identification, metabolomic and regulatory network models, functional elucidation of genetic dark matter, genomic structural anomaly detection, phylogenomic analysis of bacterial species, identification of the role of epigenetic (methylome) variations in phenotypic changes, and machine learning for causal inference in genomics and epigenetics. During the past ten years, my laboratory has focused on applying these techniques to study clinical species of M. tuberculosis collected from various parts of the world (17 countries from far east, eastern Europe, and Africa) to better understand the causation and emergence of drug resistance, virulence, and persistence. Our work, for the past ten years, has been funded by NIAID.
                  • Corey Watson, PhD
                    Assistant Professor, Department of Biochemistry and Molecular Genetics, University of Louisville School of Medicine
                    Biography
                      My research interests span the fields of molecular, population, evolutionary, and disease genetics/epigenetics, using both human and animal model systems. The primary projects in my lab are currently focused on characterizing and cataloguing antibody genetic diversity in human populations, laboratory mouse strains, and the rhesus macaque. Our ultimate aim is to understand how genetic/epigenetic variation influences antibody function and the development of the immune response, and how this information can be leveraged to inform our understanding of disease susceptibility and clinical health outcomes.
                    Sponsored By

                    For information on becoming a sponsor or exhibitor, please click here.


                    C.E. Credits

                    The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                    Committee

                    To download the Program Committee brochure here.


                    • Matthew Flegal

                      Matt entered the research field over 20 years ago as a lab animal technician at the TSI/Mason contract research facility. He has worked at both contract facilities such as TSI and OREAD Biosafety as well in industry at Pharmacia, Pfizer, and Sanofi-Aventis. During that period he ...

                      See more See less
                    • Jonas Korlach

                      Jonas Korlach was appointed Chief Scientific Officer of Pacific Biosciences in July 2012. He was previously a Scientific Fellow, supporting commercial development of the PacBio RS II system and performing research aimed at developing new applications for SMRT technologies. He ...

                      See more See less
                    Help

                    General LabRoots Questions

                    For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                    Contact us

                    Virtual Events and Webinars

                    Supported Configurations

                    • Operating System Internet Explorer Firefox Chrome Safari
                      Vista IE8+ FF10+ Chrome15+
                      Windows 7 IE8+ FF10+ Chrome15+
                      Windows 8 IE10 FF10+ Chrome15+
                      Mac OS X   FF10+ Chrome15+ Safari5.1+
                    • Cookie settings: session cookies enabled
                    • Browser configuration must have JavaScript enabled
                    • Adobe Flash player 10.2 or later

                    To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                    Internet Connection

                    • A minimum of 100Kbps is recommended for audio-only events
                    • A minimum of 300Kbps is recommended for speaker on-video events

                    Computer Equipment

                    • Screen Resolution: Minimum 1024x768
                    • Video Card: 65,000 colors minimum
                    • Sound card and speakers (or headphones) for hearing webcast in full format
                    • Audio Card: 16-bit minimum
                    • RAM: 512MB of free RAM

                    Firewall Protocol

                    • HTTP on port 80 or HTTPS on port 443
                    • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                    • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                    Work-At-Home Attendees

                    • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                    For A Seamless Experience

                    When using a mobile device, FREE Mobile Apps are available:

                    - For viewing Webinars:

                    - For viewing Virtual Events

                    Attendee Guide

                    • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                    Virtual Event and Webinar Support:

                    Continuing Education (CME/CE) Support

                    Show Resources